A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...
PRESS RELEASEAB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV DEMONSTRATING SUBSTANTIAL SURVIVAL BENEFITS AND PRESERVED QUALITY OF LIFE WITH ...
Masitinib is an experimental oral therapy for ALS that's aimed at slowing disease progression. AB Science secured insurance ...
There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...
A new study reveals that gut bacteria may play a key role in triggering ALS and frontotemporal dementia. Harmful sugars ...
Some patients with a rare form of ALS benefited from an experimental therapy, with biomarker evidence of reduced injury to neurons and even limited functional recovery. When Columbia neurologist and ...
Add Yahoo as a preferred source to see more of our stories on Google. Long-term air pollution exposure may raise ALS risk and speed disease progression, according to a large Swedish study. (CREDIT: AI ...
The study found that about one-third of hospitalized ALS patients experienced difficulty swallowing (dysphagia), and these patients had longer hospital stays, higher healthcare costs, and a greater ...
Add Yahoo as a preferred source to see more of our stories on Google. There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results